AIDS/HIV. Converging on an HIV vaccine (Q45008312)

8 December 2017

AIDS/HIV. Converging on an HIV vaccine (English)

1 reference

8 December 2017

0 references

0 references

1

1 reference

8 December 2017

2

1 reference

PubMed ID

21921189

8 December 2017

language of work or name

English

0 references

publication date

1 September 2011

1 reference

8 December 2017

1 reference

8 December 2017

333

1 reference

8 December 2017

6049

1 reference

8 December 2017

1589-1590

1 reference

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

8 December 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

Scaling up ART treatment capacity: lessons learned from South Africa, Zimbabwe, and Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

Induction of immunity to human immunodeficiency virus type-1 by vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

Characteristics of the earliest cross-neutralizing antibody response to HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

Antibody evolution constrains conformational heterogeneity by tailoring protein dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1211919

21 January 2018

Identifiers

DOI

10.1126/SCIENCE.1211919

1 reference

8 December 2017

1 reference

PubMed ID

21921189